BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22021427)

  • 21. [Polyglutamine diseases: a pathologic view].
    Yamada M
    Rinsho Shinkeigaku; 2003 Nov; 43(11):903-5. PubMed ID: 15152499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging polyglutamine deposits in brain tissue.
    Osmand AP; Berthelier V; Wetzel R
    Methods Enzymol; 2006; 412():106-22. PubMed ID: 17046655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aggregation and toxicity of the proteins with polyQ repeats].
    Leźnicki P
    Postepy Biochem; 2005; 51(2):215-22. PubMed ID: 16209359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A method for the incremental expansion of polyglutamine repeats in recombinant proteins.
    Robertson AL; Bottomley SP
    Methods Mol Biol; 2013; 1017():73-83. PubMed ID: 23719908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
    Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
    Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial frontotemporal dementia with neuronal intranuclear inclusions is not a polyglutamine expansion disease.
    Mackenzie IR; Butland SL; Devon RS; Dwosh E; Feldman H; Lindholm C; Neal SJ; Ouellette BF; Leavitt BR
    BMC Neurol; 2006 Aug; 6():32. PubMed ID: 16945149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanded polyglutamine domain possesses nuclear export activity which modulates subcellular localization and toxicity of polyQ disease protein via exportin-1.
    Chan WM; Tsoi H; Wu CC; Wong CH; Cheng TC; Li HY; Lau KF; Shaw PC; Perrimon N; Chan HY
    Hum Mol Genet; 2011 May; 20(9):1738-50. PubMed ID: 21300695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila.
    Marsh JL; Walker H; Theisen H; Zhu YZ; Fielder T; Purcell J; Thompson LM
    Hum Mol Genet; 2000 Jan; 9(1):13-25. PubMed ID: 10587574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CAG repeat disorder models and human neuropathology: similarities and differences.
    Yamada M; Sato T; Tsuji S; Takahashi H
    Acta Neuropathol; 2008 Jan; 115(1):71-86. PubMed ID: 17786457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical analysis of oligomerization of expanded polyalanine repeat proteins.
    Nojima J; Oma Y; Futai E; Sasagawa N; Kuroda R; Turk B; Ishiura S
    J Neurosci Res; 2009 Aug; 87(10):2290-6. PubMed ID: 19301421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single amino acid and trinucleotide repeats: function and evolution.
    Faux N
    Adv Exp Med Biol; 2012; 769():26-40. PubMed ID: 23560303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neurodegenerative polyglutamine expansion diseases: physiopathology and therapeutic strategies].
    Ravache M; Abou-Sleymane G; Trottier Y
    Pathol Biol (Paris); 2010 Oct; 58(5):357-66. PubMed ID: 20299163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease.
    Jung J; Bonini N
    Science; 2007 Mar; 315(5820):1857-9. PubMed ID: 17332375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1.
    Kazemi-Esfarjani P; Benzer S
    Hum Mol Genet; 2002 Oct; 11(21):2657-72. PubMed ID: 12354791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alanine tracts: the expanding story of human illness and trinucleotide repeats.
    Brown LY; Brown SA
    Trends Genet; 2004 Jan; 20(1):51-8. PubMed ID: 14698619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurodegeneration: RNA turns number one suspect in polyglutamine diseases.
    Birman S
    Curr Biol; 2008 Aug; 18(15):R659-R661. PubMed ID: 18682207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway.
    Berger Z; Ttofi EK; Michel CH; Pasco MY; Tenant S; Rubinsztein DC; O'Kane CJ
    Hum Mol Genet; 2005 Oct; 14(20):3003-11. PubMed ID: 16141285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling and analysis of repeat RNA toxicity in Drosophila.
    Samaraweera SE; O'Keefe LV; van Eyk CL; Lawlor KT; Humphreys DT; Suter CM; Richards RI
    Methods Mol Biol; 2013; 1017():173-92. PubMed ID: 23719916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins.
    Slepko N; Bhattacharyya AM; Jackson GR; Steffan JS; Marsh JL; Thompson LM; Wetzel R
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14367-72. PubMed ID: 16980414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic suppression of polyglutamine toxicity in Drosophila.
    Kazemi-Esfarjani P; Benzer S
    Science; 2000 Mar; 287(5459):1837-40. PubMed ID: 10710314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.